Primer on the Science of In Vitro Dissolution Testing of Oral Dosage Forms and Factors Influencing its Biological Relevance

被引:3
|
作者
Fahmy, Raafat [1 ]
Martinez, Marilyn N. [1 ]
机构
[1] US FDA, Off New Anim Drug Evaluat, Ctr Vet Med, Rockville, MD 20857 USA
来源
DISSOLUTION TECHNOLOGIES | 2019年 / 26卷 / 01期
关键词
In vitro dissolution; formulation effects; oral drug absorption; in vivo-in vitro relationships; ADVANCED DRUG-DELIVERY; BIOPHARMACEUTICAL CLASSIFICATION; PHARMACEUTICAL EXCIPIENTS; VIVO PERFORMANCE; UNITED-STATES; BIORELEVANT DISSOLUTION; GASTROINTESTINAL-TRACT; QUALITY-CONTROL; BIOAVAILABILITY; TABLETS;
D O I
10.14227/DT260119P14
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
In vitro dissolution testing can serve as an effective and efficient tool for evaluating the influence of formulation and manufacturing variables on drug release characteristics. The targeted purpose will determine the method used and the implications of the test results. Regardless of its intended purpose, it is necessary to understand the factors influencing in vitro dissolution outcomes to avoid the introduction of error into the data interpretation. This will influence the selection of the in vitro test procedure, ensuring that the method can identify changes in the critical formulation and manufacturing variables. There is also a need to understand the rate limiting factors influencing in vivo product bioavailability both from a dissolution and an absorption perspective. Finally, to achieve in vivo biorelevance, it is necessary to understand how the selected in vitro dissolution test method reflects the variables impacting in vivo product dissolution behavior. This primer summarizes and integrates these diverse variables, fostering an appreciation of the strengths and potential pitfalls that may be encountered during the generation and analysis of in vitro dissolution profiles associated with oral dosage forms. This understanding is needed for developing a well-designed dissolution test procedure that is appropriately fit for purpose.
引用
收藏
页码:14 / 26
页数:13
相关论文
共 40 条
  • [31] Rational Dispensing of Oral Dosage Forms of Medicines to Children and Its Associated Factors in South West Ethiopia
    Ejeta, Fikadu
    Feyisa, Diriba
    Aferu, Temesgen
    Siraj, Jafer
    Melkam, Demeke
    Ali, Ahmed
    PEDIATRIC HEALTH MEDICINE AND THERAPEUTICS, 2022, 13 : 103 - 113
  • [32] CONVENTIONAL VERSUS NOVEL CONDITIONS FOR THE IN-VITRO DISSOLUTION TESTING OF PARENTERAL SLOW-RELEASE FORMULATIONS - APPLICATION TO DOXEPIN PARENTERAL DOSAGE FORMS
    GIDO, C
    LANGGUTH, P
    KREUTER, J
    WINTER, G
    WOOG, H
    MUTSCHLER, E
    PHARMAZIE, 1993, 48 (10): : 764 - 769
  • [33] Developing dissolution testing methodologies for extended-release oral dosage forms with supersaturating properties. Case example: Solid dispersion matrix of indomethacin
    Tajiri, Tomokazu
    Morita, Shigeaki
    Sakamoto, Ryosaku
    Mimura, Hisahi
    Ozaki, Yukihiro
    Reppas, Christos
    Kitamura, Satoshi
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2015, 490 (1-2) : 368 - 374
  • [34] Introduction to the OrBiTo decision tree to select the most appropriate in vitro methodology for release testing of solid oral dosage forms during development
    Andreas, C. J.
    Rosenberger, J.
    Butler, J.
    Augustijns, P.
    McAllister, M.
    Abrahamsson, B.
    Dressman, J.
    EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2018, 130 : 207 - 213
  • [35] In Vitro Predictive Dissolution Test Should Be Developed and Recommended as a Bioequivalence Standard for the Immediate-Release Solid Oral Dosage Forms of the Highly Variable Mycophenolate Mofetil
    Wang, Kai
    Li, Yangbing
    Chen, Bing
    Chen, Hao
    Smith, David E.
    Sun, Duxin
    Feng, Meihua R.
    Amidon, Gordon L.
    MOLECULAR PHARMACEUTICS, 2022, : 2048 - 2060
  • [36] Predicting the oral pharmacokinetic profiles of multiple-unit (pellet) dosage forms using a modeling and simulation approach coupled with biorelevant dissolution testing: Case example diclofenac sodium
    Kambayashi, Atsushi
    Blume, Henning
    Dressman, Jennifer B.
    EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2014, 87 (02) : 236 - 243
  • [37] Predicting in vivo absorption behavior of oral modified release dosage forms containing pH-dependent poorly soluble drugs using a novel pH-adjusted biphasic in vitro dissolution test
    Heigoldt, Ulrich
    Sommer, Florian
    Daniels, Rolf
    Wagner, Karl-Gerhard
    EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2010, 76 (01) : 105 - 111
  • [38] Stability indicating high-performance liquid chromatography method for determining doxycycline hyclate and related substances in their various dosage forms: Utilizing Six Sigma tools, uniformity testing, and in-vitro dissolution approaches
    Mahmoud, Osama A.
    Omran, Ahmed A.
    Gomaa, Hosni A.
    Mohamed, Mahmoud A.
    SEPARATION SCIENCE PLUS, 2024, 7 (02)
  • [39] In Vitro Dissolution of Generic Immediate-Release Solid Oral Dosage Forms Containing BCS Class I Drugs: Comparative Assessment of Metronidazole, Zidovudine, and Amoxicillin Versus Relevant Comparator Pharmaceutical Products in South Africa and India
    Reddy, Nallagundla H. S.
    Patnala, Srinivas
    Loebenberg, Raimar
    Kanfer, Isadore
    AAPS PHARMSCITECH, 2014, 15 (05): : 1076 - 1086
  • [40] In Vitro Dissolution of Generic Immediate-Release Solid Oral Dosage Forms Containing BCS Class I Drugs: Comparative Assessment of Metronidazole, Zidovudine, and Amoxicillin Versus Relevant Comparator Pharmaceutical Products in South Africa and India
    Nallagundla H. S. Reddy
    Srinivas Patnala
    Raimar Löbenberg
    Isadore Kanfer
    AAPS PharmSciTech, 2014, 15 : 1076 - 1086